(Q43758413)

English

TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats (English)

1 reference

Europe PubMed Central

26 November 2017

author name string

Mizisin AP

1

1 reference

Europe PubMed Central

26 November 2017

Steinhardt RC

2

1 reference

Europe PubMed Central

26 November 2017

O'Brien JS

3

1 reference

Europe PubMed Central

26 November 2017

Calcutt NA

4

1 reference

Europe PubMed Central

26 November 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

26 November 2017

Journal of Neuropathology & Experimental Neurology

1 reference

Europe PubMed Central

26 November 2017

60

1 reference

Europe PubMed Central

26 November 2017

10

1 reference

Europe PubMed Central

26 November 2017

953-960

1 reference

Europe PubMed Central

26 November 2017

Clinical Trials of Diabetic Neuropathy: Past, Present, and Future

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Neurotrophic factors and diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

NT-3 attenuates functional and structural disorders in sensory nerves of galactose-fed rats

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Secretion of sphingolipid hydrolase activator precursor, prosaposin

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury.

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Differentially expressed genes after peripheral nerve injury

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Cellular pathology of the nerve microenvironment in galactose intoxication

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Role of advanced glycation end-products (AGE) in late diabetic complications.

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F60.10.953

21 January 2018

Identifiers

10.1093/JNEN/60.10.953

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43758413&oldid=2103087214"